Grossmann, Elisa
Schilling, Hannah-Lou
Magnussen, Christina
Funding for this research was provided by:
Universitätsklinikum Hamburg-Eppendorf (UKE)
Article History
Received: 30 January 2026
Accepted: 10 March 2026
First Online: 19 March 2026
Change Date: 25 March 2026
Change Type: Update
Change Details: The original version of this paper was updated to fix a formatting error in the title.
Declarations
:
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: EG and HLS declare that they have no conflict of interest. CM received study-specific funding from the German Center for Cardiovascular Research (DZHK; Promotion of women scientists programme; FKZ 81X3710112), the Deutsche Stiftung für Herzforschung, the Dr. Rolf M. Schwiete Stiftung, NDD, and Loewenstein Medical unrelated to the current work. CM received speaker fees from Edwards, AstraZeneca, Novartis, Boehringer Ingelheim/Lilly, Bayer, and Novo Nordisk outside this work. CM has participated in advisory boards for Boehringer Ingelheim, Alnylam and Novo Nordisk.